Skip to main content
. 2019 Feb 15;7(5):338–344. doi: 10.1093/gastro/goy053

Table 1.

Difference between high-risk human papilloma virus (HPV)-positive and -negative patients in demographic characteristics

Patients without high-risk HPV infection Patients with high-risk HPV infection P-value
Crohn’s disease N = 81 N = 13
Age, years 34.56 ± 4.61 36.15 ± 7.25 0.427
Disease duration, years 4.26 ± 3.63 8.69 ± 9.17 0.14
Family history, n (%) 0 (0.0) 0 (0.0)
Behavior, n (%) 0.839
  B1 (non-stricturing, non-penetrating) 45 (55.6) 6 (46.2)
  B2 (structuring) 13 (16.0) 2 (15.4)
  B3 (penetrating) 23 (28.4) 5 (38.4)
Location, n (%) 0.505
  L1 (terminal ileum) 12 (14.8) 2 (15.4)
  L2 (colon) 7 (8.6) 0 (0.0)
  L3 (ileocolon) 48 (59.3) 10 (76.9)
  L4 (upper gastrointestinal tract) 14 (17.3) 1 (7.7)
Smoking, n (%) 8 (9.9) 1 (7.7) 1.000
Extra-intestinal manifestation, n (%) 15 (18.5) 1 (7.7) 0.571
Perianal disease, n (%) 36 (44.4) 5 (38.5) 0.686
Ulcerative colitis N = 26 N = 4
Age, years 39.24 ± 8.72 35.75 ± 6.02 0.450
Disease duration, years 4.01 ± 3.57 6.17 ± 3.09 0.266
Family history, n (%) 0 (0.0) 0 (0.0)
Location, n (%) 0.662
  E1 (ulcerative proctitis) 4 (15.4) 0 (0.0)
  E2 (left-sided) 4 (15.4) 1 (25.0)
  E3 (extensive) 18 (69.2) 3 (75.0)
Smoking, n (%) 0 (0.0) 0 (0.0)
Extra-intestinal manifestation, n (%) 1 (3.8) 0 (0.0) 1.000